Joseph Edelman – IOVA history
- Issuer:
- IOVANCE BIOTHERAPEUTICS INC
- Quarters tracked:
- 35 (Q2 2017 → Q1 2026)
- Current shares:
- 0
- Current value:
- $0
- Peak shares:
- 26,617,709 (Q3 2024)
- Overall change:
- -100%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | SOLD | — | — | -152,714 | -100% |
| Q4 2025 | 152,714 | $417K | $2.73 | +152,714 | +100% |
| Q2 2025 | SOLD | — | — | -12,711,788 | -100% |
| Q1 2025 | 12,711,788 | $42.33M | $3.33 | -9,400,478 | -43% |
| Q4 2024 | 22,112,266 | $163.63M | $7.40 | -4,505,443 | -17% |
| Q3 2024 | 26,617,709 | $249.94M | $9.39 | +684,567 | +3% |
| Q2 2024 | 25,933,142 | $207.98M | $8.02 | +6,660,151 | +35% |
| Q1 2024 | 19,272,991 | $285.63M | $14.82 | +7,293,576 | +61% |
| Q4 2023 | 11,979,415 | $97.39M | $8.13 | +16,477 | 0% |
| Q3 2023 | 11,962,938 | $54.43M | $4.55 | -2,073,472 | -15% |
| Q2 2023 | 14,036,410 | $98.82M | $7.04 | -1,303,325 | -8% |
| Q1 2023 | 15,339,735 | $93.73M | $6.11 | +5,367,955 | +54% |
| Q4 2022 | 9,971,780 | $63.72M | $6.39 | -276,844 | -3% |
| Q3 2022 | 10,248,624 | $98.18M | $9.58 | -1,577,675 | -13% |
| Q2 2022 | 11,826,299 | $130.56M | $11.04 | -374,962 | -3% |
| Q1 2022 | 12,201,261 | $203.15M | $16.65 | +2,073,320 | +20% |
| Q4 2021 | 10,127,941 | $193.34M | $19.09 | -1,361,831 | -12% |
| Q3 2021 | 11,489,772 | $283.34M | $24.66 | +530,000 | +5% |
| Q2 2021 | 10,959,772 | $285.17M | $26.02 | +2,307,987 | +27% |
| Q1 2021 | 8,651,785 | $273.92M | $31.66 | -514,519 | -6% |
| Q4 2020 | 9,166,304 | $425.32M | $46.40 | -919,328 | -9% |
| Q3 2020 | 10,085,632 | $332.02M | $32.92 | -1,723,862 | -15% |
| Q2 2020 | 11,809,494 | $324.17M | $27.45 | +139,437 | +1% |
| Q1 2020 | 11,670,057 | $349.34M | $29.93 | +2,253,855 | +24% |
| Q4 2019 | 9,416,202 | $260.64M | $27.68 | -1,598,500 | -15% |
| Q3 2019 | 11,014,702 | $200.47M | $18.20 | -900,425 | -8% |
| Q2 2019 | 11,915,127 | $292.16M | $24.52 | -320,684 | -3% |
| Q1 2019 | 12,235,811 | $116.36M | $9.51 | -5,300 | 0% |
| Q4 2018 | 12,241,111 | $108.33M | $8.85 | +4,950,912 | +68% |
| Q3 2018 | 7,290,199 | $82.01M | $11.25 | +1,437,997 | +25% |
| Q2 2018 | 5,852,202 | $74.91M | $12.80 | -310,000 | -5% |
| Q1 2018 | 6,162,202 | $104.14M | $16.90 | +1,386,088 | +29% |
| Q4 2017 | 4,776,114 | $38.21M | $8.00 | +50,000 | +1% |
| Q3 2017 | 4,726,114 | $36.63M | $7.75 | +363,000 | +8% |
| Q2 2017 | 4,363,114 | $32.07M | $7.35 | — | NEW |